# OnCo record zg006 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/zg006/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "zg006" ;
  schema:name "ZG006"@en ;
  schema:description "ZG006 is an experimental investigational agent whose form is not stated in the registry from Suzhou Zelgen Biopharmaceuticals in phase 3 trials for non-small-cell lung cancer and neuroendocrine tumours, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/zg006/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=ZG006> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "trispecific T-cell engager antibody (DLL3 x DLL3 x CD3, per the sponsor's pipeline page; form not stated in the registry record)" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/neuroendocrine/> ;
  onco:companies <https://onco.cc/companies/zelgen/> ;
  onco:trials <https://onco.cc/trials/nct07189455/>, <https://onco.cc/trials/nct05978284/>, <https://onco.cc/trials/nct06283719/>, <https://onco.cc/trials/nct07038096/>, <https://onco.cc/trials/nct07258121/>, <https://onco.cc/trials/nct06440057/> .